Skip to main content

Table 3 Diagnostic accuracy of the TyG-BMI

From: The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population

 

Cut-off

No

SP (%)

SE (%)

PPV (%)

NPV (%)

PLR

NLR

Youden’s index

Development

 ≥ 137.4

6405

12.2

99.9

19.8

99.9

1.14

0.006

0.121

 ≥ 147.8

5705

24.2

99.5

22.2

99.6

1.31

0.020

0.237

 ≥ 156.7

4998

35.9

98.5

25.1

99.1

1.54

0.042

0.344

 ≥ 165.0

4264

48.2

97.1

29.0

98.7

1.87

0.060

0.453

 ≥ 173.3

3541

60.0

94.3

33.9

98.0

2.36

0.094

0.543

 ≥ 182.2

2829

71.1

89.4

40.2

96.9

3.09

0.149

0.605

 ≥ 192.8

2113

81.2

79.6

48.0

94.8

4.25

0.251

0.608

 ≥ 205.4

1396

90.2

64.9

59.1

92.2

6.64

0.389

0.551

 ≥ 224.0

686

96.6

38.1

70.7

87.8

11.09

0.641

0.347

Validation

 ≥ 137.4

6447

12.1

99.8

19.3

99.7

1.14

0.013

0.119

 ≥ 147.8

5719

24.4

99.6

21.7

99.7

1.32

0.017

0.240

 ≥ 156.7

4998

36.3

99.0

24.6

99.4

1.55

0.029

0.353

 ≥ 165.0

4304

47.8

97.6

28.2

98.9

1.87

0.050

0.454

 ≥ 173.3

3599

59.1

94.3

32.6

98.0

2.30

0.097

0.534

 ≥ 182.2

2883

70.1

89.2

38.5

96.9

2.98

0.154

0.593

 ≥ 192.8

2171

80.0

79.2

45.5

94.8

3.97

0.260

0.592

 ≥ 205.4

1460

89.0

65.2

55.4

92.4

5.92

0.391

0.542

≥ 224.0

742

96.3

41.8

70.1

88.7

11.18

0.605

0.381

  1. PPV positive predictive value, SP specificity, NPV negative predictive value, SE sensitivity, PLR positive likelihood ratio, NLR negative likelihood ratio, TyG-BMI triglyceride glucose-body mass index